Shen AI Vitals is now ANVISA approved
Shen AI Vitals has officially received ANVISA approval, confirming its readiness for use in regulated digital health solutions across Brazil.
Shen AI Vitals receives ANVISA approval as a class II medical device in Brazil
Shen AI Vitals has officially received ANVISA approval. This marks a major milestone in our mission to deliver clinically trusted, contactless health insights across digital health, insurance, and telemedicine platforms.
ANVISA (Agência Nacional de Vigilância Sanitária) is Brazil’s National Health Surveillance Agency and one of the most respected regulatory bodies in Latin America. Its approval of Shen AI Vitals confirms that our technology meets the safety, performance, and regulatory requirements for use in Brazil’s healthcare ecosystem.
What ANVISA approval involves
Shen AI Vitals is registered with ANVISA under approval number 81464750186 under RDC 751/2022 as a class II medical device under rule 11 (software that monitors physiological functions) for mobile and web deployment.
All signal processing and metric extraction are performed locally on the user’s device, ensuring compliance with relevant privacy standards.
Enabling faster integration in regulated LATAM markets
With ANVISA approval in place, Shen.AI Vitals is now available for integration into regulated digital health solutions across Brazil. This enables developers, healthcare providers, and insurers to:
- Confidently integrate contactless, clinically validated health monitoring into their platforms
- Streamline compliance for solutions involving physiological measurements
- Accelerate development cycles and reduce regulatory complexity
- Offer real-time health insights to broader populations without requiring wearables or external hardware
This opens the door to new use cases in teleconsultation, chronic care, remote triage, and digital wellness, all powered by a face scan with a standard device camera.
What Shen.AI Vitals measures
Shen AI Vitals provides real-time estimates of heart rate and heart rate variability (HRV) as well as respiratory rate with contactless, camera-based measurements. The health metrics are derived using remote photoplethysmography (rPPG) - with no need for wearables or external sensors.
See what’s possible with Shen AI Vitals
With ANVISA approval, Shen AI Vitals is now part of the regulated digital health landscape in Brazil. If you're exploring ways to bring real-time, camera-based health insights into your product -without adding hardware or complexity - we’d love to show you how it works.
Schedule a demo and see how it could fit into your roadmap.
More blog posts
Sagittis et eu at elementum, quis in. Proin praesent volutpat egestas sociis sit lorem nunc nunc sit.
How to choose a vendor for vital signs monitoring
Choosing a vital signs monitoring provider can be tricky. This guide breaks down what truly matters — from accuracy and inclusivity to integration, user experience, and long-term scalability — so you can select a solution built for real-world performance.
Multimodal approach by Shen AI using remote photoplethysmography (rPPG) and ballistocardiography (rBCG) for heart rate and heart rate variability prediction
Shen AI’s multimodal rPPG+rBCG system delivers high-accuracy, equitable heart rate and HRV monitoring across 5,000+ participants, improving SDNN by up to 18% in darker skin tones.
Facial video photoplethysmography for measuring average and quasi-instantaneous heart rate
Facial vPPG matched ECG with up to 1-bpm precision - even for 4-second, quasi-instantaneous heart rate readings - showcasing the potential of accurate, contactless monitoring.